Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-14 | Acrivon Therapeutics, Inc. | Peterson Katharine
(Chief Accounting Officer) |
F | Common Stock | D | 99 | $8.36 - $8.36 | $827 |
| 2024-05-14 | Acrivon Therapeutics, Inc. | Miller Mary
(Chief Legal Officer) |
F | Common Stock | D | 184 | $8.36 - $8.36 | $1,538 |
| 2024-05-14 | Acrivon Therapeutics, Inc. | Masson Kristina
(EVP - Business Operations) |
F | Common Stock | D | 490 | $8.36 - $8.36 | $4,096 |
| 2024-05-14 | Acrivon Therapeutics, Inc. | Holm-Jorgensen Ra...
(Chief Financial Officer) |
F | Common Stock | D | 368 | $8.36 - $8.36 | $3,076 |
| 2024-05-14 | Acrivon Therapeutics, Inc. | Gamelin Erick
(Chief Development Officer) |
F | Common Stock | D | 402 | $8.36 - $8.36 | $3,360 |
| 2024-05-14 | Acrivon Therapeutics, Inc. | Devroe Eric
(Chief Operating Officer) |
F | Common Stock | D | 613 | $8.36 - $8.36 | $5,124 |
| 2024-05-14 | Acrivon Therapeutics, Inc. | Blume-Jensen Peter
(President and CEO) |
F | Common Stock | D | 54918 | $8.36 - $8.36 | $459,114 |
| 2024-04-11 | Acrivon Therapeutics, Inc. | Shah Rajeev M.
(Director) |
A | Common Stock | A | 3530000 | $8.50 - $8.50 | $30,005,000 |
| 2024-04-11 | Acrivon Therapeutics, Inc. | EDELMAN JOSEPH
(AtLeastTenPercentOwner) |
P | Common Stock | A | 2353000 | $8.50 - $8.50 | $20,000,500 |
| 2024-02-14 | Acrivon Therapeutics, Inc. | Devroe Eric
(Chief Operating Officer) |
F | Common Stock | D | 723 | $3.40 - $3.40 | $2,458 |
| 2024-02-14 | Acrivon Therapeutics, Inc. | Blume-Jensen Peter
(President and CEO) |
F | Common Stock | D | 41861 | $3.40 - $3.40 | $142,327 |
| 2024-01-17 | Acrivon Therapeutics, Inc. | Miller Mary
(Chief Legal Officer) |
F | Common Stock | D | 652 | $4.35 - $4.35 | $2,836 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |